Andrew Gaffney

Andrew Gaffney possesses extensive experience in the biotechnology sector, having held various leadership positions at STEMCELL Technologies from 2014 to present, including Director of Stem Cell Manufacturing and Commercialization and Associate Director of iPSC and Differentiated Cells. Prior roles at STEMCELL Technologies also include Senior Manager of Strategic Alliances and Senior Product Manager for Pluripotent Stem Cell Biology. Andrew Gaffney’s career began as a Key Account Manager at Sigma Aldrich from 2012 to 2014 and included a position in Compound Management at AstraZeneca in 2005. Academic qualifications include a PhD from the University of Leeds focused on modeling Ewing sarcoma with human embryonic stem cells, a Master of Science in Genetic Epidemiology from the University of Sheffield, and a Bachelor of Science in Biology with Genomics also from the University of Sheffield.